Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.

Tosoian JJ, Zhang Y, Xiao L, Xie C, Samora NL, Niknafs YS, Chopra Z, Siddiqui J, Zheng H, Herron G, Vaishampayan N, Robinson HS, Arivoli K, Trock BJ, Ross AE, Morgan TM, Palapattu GS, Salami SS, Kunju LP, Tomlins SA, Sokoll LJ, Chan DW, Srivastava S, Feng Z, Sanda MG, Zheng Y, Wei JT, Chinnaiyan AM, EDRN-PCA3 Study Group

Open source

DOI: 10.1001/jamaoncol.2024.0455
Published: 2024 Jun 1
Container: JAMA oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamaoncol.2024.0455,
  title = {Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.},
  author = {Tosoian JJ and Zhang Y and Xiao L and Xie C and Samora NL and Niknafs YS and Chopra Z and Siddiqui J and Zheng H and Herron G and Vaishampayan N and Robinson HS and Arivoli K and Trock BJ and Ross AE and Morgan TM and Palapattu GS and Salami SS and Kunju LP and Tomlins SA and Sokoll LJ and Chan DW and Srivastava S and Feng Z and Sanda MG and Zheng Y and Wei JT and Chinnaiyan AM and EDRN-PCA3 Study Group},
  year = {2024},
  journal = {JAMA oncology},
  doi = {10.1001/jamaoncol.2024.0455},
  url = {https://doi.org/10.1001/jamaoncol.2024.0455}
}

RIS

TY  - JOUR
TI  - Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.
AU  - Tosoian JJ
AU  - Zhang Y
AU  - Xiao L
AU  - Xie C
AU  - Samora NL
AU  - Niknafs YS
AU  - Chopra Z
AU  - Siddiqui J
AU  - Zheng H
AU  - Herron G
AU  - Vaishampayan N
AU  - Robinson HS
AU  - Arivoli K
AU  - Trock BJ
AU  - Ross AE
AU  - Morgan TM
AU  - Palapattu GS
AU  - Salami SS
AU  - Kunju LP
AU  - Tomlins SA
AU  - Sokoll LJ
AU  - Chan DW
AU  - Srivastava S
AU  - Feng Z
AU  - Sanda MG
AU  - Zheng Y
AU  - Wei JT
AU  - Chinnaiyan AM
AU  - EDRN-PCA3 Study Group
PY  - 2024
JO  - JAMA oncology
DO  - 10.1001/jamaoncol.2024.0455
UR  - https://doi.org/10.1001/jamaoncol.2024.0455
ER  -

APA

JJ, T., Y, Z., L, X., C, X., NL, S., YS, N., Z, C., J, S., H, Z., G, H., N, V., HS, R., K, A., BJ, T., AE, R., TM, M., GS, P., SS, S., LP, K., SA, T., LJ, S., DW, C., S, S., Z, F., MG, S., Y, Z., JT, W., AM, C., & Group, E. S. (2024). Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.. JAMA oncology. https://doi.org/10.1001/jamaoncol.2024.0455

Source records

pubmed · retrieved 2026-09-26T05:24:12.821Z